Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scilex Holding (SCLX) Research & Development (2022 - 2025)

Scilex Holding (SCLX) has 4 years of Research & Development data on record, last reported at $3.9 million in Q3 2025.

  • For Q3 2025, Research & Development rose 65.99% year-over-year to $3.9 million; the TTM value through Sep 2025 reached $14.7 million, up 44.4%, while the annual FY2024 figure was $9.6 million, 24.36% down from the prior year.
  • Research & Development reached $3.9 million in Q3 2025 per SCLX's latest filing, down from $6.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $6.2 million in Q2 2025 and bottomed at $1.2 million in Q3 2022.
  • Average Research & Development over 4 years is $2.9 million, with a median of $2.6 million recorded in 2022.
  • Peak YoY movement for Research & Development: skyrocketed 229.18% in 2023, then plummeted 42.31% in 2024.
  • A 4-year view of Research & Development shows it stood at $2.6 million in 2022, then grew by 5.28% to $2.7 million in 2023, then dropped by 20.26% to $2.2 million in 2024, then soared by 78.85% to $3.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $3.9 million in Q3 2025, $6.2 million in Q2 2025, and $2.5 million in Q1 2025.